Back to Journals » Cancer Management and Research » Volume 14

Feasibility and Tolerability of Lenvatinib, Plus PD-1 Blockades for Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study

Total article views   HTML views PDF downloads Totals
3,675 Dovepress* 3,608+ 134 3,742
PubMed Central* 67 54 121
Totals 3,675 188 3,863
*Since 2 September 2022

View citations on PubMed Central and Google Scholar